Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer
about
Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentAn ocular view of the IGF-IGFBP systemIGF binding proteins in cancer: mechanistic and clinical insightsDoes milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysisRegulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor.Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinomaTargeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthmaThe proliferating role of insulin and insulin-like growth factors in cancer.Activation of various downstream signaling molecules by IGFBP-3.Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.IGFBP-3 inhibits cytokine-induced insulin resistance and early manifestations of atherosclerosisNovel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury.Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases.The link between the metabolic syndrome and cancer.Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional eventsThe coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ)Association between height and malignancy among children in the north of Iran.Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis.The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC).Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions.Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions.Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma.Insulin-like growth factor: current concepts and new developments in cancer therapy.Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses.Insulin-like growth factor binding protein-3 links obesity and breast cancer progression.Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3.Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms.Insulin-like growth factor-binding protein-6 and cancer.Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.Novel transcription-induced fusion RNAs in prostate cancer.Connecting myelin-related and synaptic dysfunction in schizophrenia with SNP-rich gene expression hubs.Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cells.IGF binding protein-3 mediates stress-induced apoptosis in non-transformed mammary epithelial cells.IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses.Role of insulin-like growth factor binding protein-3 in 1, 25-dihydroxyvitamin-d 3 -induced breast cancer cell apoptosis.Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide.
P2860
Q26798408-0634A7AC-C844-4ACD-A74C-8DD823BE8C2CQ27013698-5E4C094A-F62B-456D-B52D-40F89FCED195Q28237971-9B364A78-1AD5-412E-AF43-D26F626316A5Q30235013-E58E5D4D-83B5-45D1-97A9-1BE2ADD4B197Q33632210-47FAB1EB-6BE2-4905-89A0-F346A79E272BQ33685277-8F509DF6-7992-45D1-9FCC-6D2234B4106AQ33756365-456DC5C2-96A7-4DA5-9E54-9E7DED74A0AFQ34172625-DED0983A-3150-4586-8493-C8416A1A0C5EQ34219109-BF8D5F42-9F72-437C-B269-1722BA9326F8Q34335696-9531C532-425E-46C6-9215-EC258BA3277AQ34576044-32993846-8066-4410-82C7-BD0EE04E5B2BQ34805398-1C819691-C12E-4B9B-A8FF-BA569EE03154Q34979016-3A026F2C-8129-4148-9613-77746F989986Q35187561-74E350F5-36A3-4B23-9E7B-D1641FD3FAF7Q35197405-0A435A48-B6D2-452C-B014-882AA8985F04Q35561072-C47F6B9F-CFF9-433A-BA0D-F883E4B0939BQ35763352-8E7376EF-CF51-4045-B4AC-886988D8C50EQ35801047-DDE890D3-7B6F-432D-8922-E93E49D8D204Q35973274-F1C67CB3-6E49-4A8A-91D0-5419A302CCA7Q36468522-8E77126C-782E-427F-BA22-A0C001230F85Q36740292-6C5A8C53-8B73-45E0-8C15-9FAA14DE7081Q36766116-CA489FEF-AF8F-4F00-8872-5D6DA3CDE8F5Q37004744-A676D665-3AF3-49BA-827A-FF2FD70955AFQ37031704-2D941A73-C3F4-4AD7-886A-0CD8EB95AD24Q37047067-1DB9D7C7-E73F-4BB3-A638-252A75704DD2Q37226250-299C0D66-204A-4D08-94B9-1BC410416F35Q37264739-6D345ABB-84E3-495E-A229-BA464DA8246EQ37688258-4BF7920C-9E87-476A-959E-E7B048EF1AADQ37927102-10D3D837-AFDF-4A28-861F-C9B1E7804CD8Q37963505-94114662-8A4E-4AEA-8D60-55BC8E367D0DQ38057775-E8A0335D-8743-40A2-9FBD-EDB20C0DA540Q38586626-D96C4D5A-E922-454D-BBF3-A6E977E031E4Q38806903-4E25A5FE-A159-4C58-9AA6-C07DA45B3E1EQ38850829-1F306E1B-C8CC-4A23-88BE-5FF1F1B9D2C9Q38911672-3A1D4F7E-1E1A-4F8B-9B55-85C69A0AAA41Q39285362-EDA504BC-D4DD-4E89-875E-4FBF953A2463Q39458425-183B15D8-ABF9-4928-AF23-0D1B084D54FDQ39461923-6CA39FAE-CD63-4C9F-9747-F8638867AD99Q40643683-80DE447F-3A7B-45A5-B31B-903F565CA364Q42175059-336727B2-9E1E-4208-A4B3-97C5C2B3AAD4
P2860
Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of a novel cell ...... in breast and prostate cancer
@ast
Identification of a novel cell ...... in breast and prostate cancer
@en
Identification of a novel cell ...... in breast and prostate cancer
@nl
type
label
Identification of a novel cell ...... in breast and prostate cancer
@ast
Identification of a novel cell ...... in breast and prostate cancer
@en
Identification of a novel cell ...... in breast and prostate cancer
@nl
prefLabel
Identification of a novel cell ...... in breast and prostate cancer
@ast
Identification of a novel cell ...... in breast and prostate cancer
@en
Identification of a novel cell ...... in breast and prostate cancer
@nl
P2093
P2860
P3181
P356
P1476
Identification of a novel cell ...... in breast and prostate cancer
@en
P2093
Aki Mikami
Amanda E Garza
Angela R Ingermann
Dae-Yeol Lee
Ho-Seong Kim
Jinfeng Han
Joy L Ware
Lathika Mohanraj
Lingbo Fan
Michael Idowu
P2860
P304
P3181
P356
10.1074/JBC.M110.122226
P407
P577
2010-09-24T00:00:00Z